Developer docs
API playgroundTry for free, no card

Search company profiles

PiezoBioMembrane

Full company profile

uuid02lx9sg

Namestring
PiezoBioMembrane
Websiteurl
https://www.piezo.bio
Company typeenum
Private
Founded yearint
2021
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersStorrs Mansfield, United States
HQ citystring
Storrs Mansfield
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

No data
Social media profiles1 record
No data
Differentiator
Functional benefit
Problem solved
No data
Market position
Customer concentration

Classification, Details

No data
API detail

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PiezoBioMembrane

piezo.bio

PiezoBioMembrane firmographics

Firmographics
Name
PiezoBioMembrane
Website
https://www.piezo.bio
Company type
Private
Founded year
2021
Headcount range
1–10 employees
Ownership category
akta.pro rank

Where PiezoBioMembrane is headquartered

Location

Headquarters

HQ city
Storrs Mansfield
HQ country
United States
HQ region
North America

Markets served

PiezoBioMembrane technology and API

Technology

API detail

API docs
API detail

Core technology

AI maturity

App detail

PiezoBioMembrane competitors and assessment

Company assessment

Market position

Customer concentration

PiezoBioMembrane social profiles

Digital presence

PiezoBioMembrane financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PiezoBioMembrane leadership team

Management profile

Number of profiles

PiezoBioMembrane funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PiezoBioMembrane M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PiezoBioMembrane

When was PiezoBioMembrane founded?

PiezoBioMembrane was founded in 2021. It employs 1 to 10 people.

Where is PiezoBioMembrane based?

PiezoBioMembrane is headquartered in Storrs Mansfield, United States, in the North America region.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InvestegateThe "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got AcquiredPetVivo Holdings acquired PiezoBioMembrane, a startup developing a biodegradable piezoelectric implant that generates electricity from joint motion to regrow cartilage. The material, invented by UConn professor Thanh Nguyen, is designed to break down safely inside the body. PetVivo aims to accelerate commercialization for both animal and human markets.UConn TodayUConn Startup Acquired by Leading Animal Health CompanyUConn-founded startup PiezoBioMembrane (PBM) has been acquired by veterinary biotech company PetVivo Holdings to advance treatments for osteoarthritis in dogs and horses. The acquisition combines PBM's biodegradable piezoelectric materials with PetVivo's commercialization capabilities, aiming to accelerate product development in animal health with potential future applications in human medicine.Investing.comEarnings call transcript: PetVivo lifts revenue in Q1 2026, but stock stays flat By Investing.comPetVivo Holdings reported a 13% increase in first-quarter revenue for the fiscal year ending June 30, 2026, amounting to $338,000, while narrowing its net loss to $1.7 million from $2.3 million a year earlier. The company's stock remained flat, reflecting a market reaction that views these improvements as modest in the context of its ongoing losses and reliance on outside financing. PetVivo plans to leverage its proprietary SPRYNG product and expand its market presence, particularly in Canada and through a recent acquisition of PiezoBioMembrane (PBM).GlobeNewswirePetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027PetVivo Holdings reported fiscal Q1 2027 results, announcing the acquisition of PiezoBioMembrane and furthering its PetVivo.ai platform beta launch. The platform reduced customer acquisition costs by 50-90% to under $43 per customer, with AI diagnosis accuracy at 97%. The company expects commercial launch within months.Stock TitanPetVivo Q1 Results, PBM Acquisition AnnouncedPetVivo Holdings reported its fiscal Q1 2027 results and announced the acquisition of PiezoBioMembrane (PBM), an R&D partner specializing in piezoelectric biomaterial technologies. The company also highlighted the beta launch of its PetVivo.ai veterinary platform, which demonstrated significant reductions in customer acquisition costs and high diagnostic accuracy.Investing.comEarnings call transcript: PetVivo’s Q4 2026 loss widens as margin pressure bites By Investing.comPetVivo Holdings reported fiscal 2026 revenue of $1.14 million, up only 1% from the prior year, while its net loss widened to $10.5 million from $8.4 million in fiscal 2025. Gross margin collapsed to 66.1% from 87.8% a year earlier, driven by lower-margin PrecisePRP product sales weighing on profitability despite management's stated shift toward higher-margin Spryng products. The company completed its acquisition of PiezoBioMembrane and received Health Canada recognition for Spryng, positioning for a Canadian launch in late July, while also advancing its PetVivo.ai AI-powered veterinary platform toward commercial launch.GlobeNewswirePetVivo Reports Financial and Operational Results for Fiscal 2026PetVivo reported fiscal 2026 results, including Q4 operational highlights and financial statements. Health Canada recognized Spryng as a veterinary medical device, and Digital Landia's AgenticPet beta launched with 1,000+ users. The company expects commercial launch of PetVivo.ai within months.GlobeNewswirePetvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional BiomaterialsPetVivo Holdings and PiezoBioMembrane announced a Master Services Agreement to jointly develop functional biomaterials combining PetVivo's ECM-like biomaterial with PiezoBio's piezoelectric nanofibers. The collaboration aims to create biologically activated materials for tissue and bone regeneration in animals and humans.